Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
9%
Ph not_applicable
8
73%
Ph phase_4
2
18%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Early Phase 1First-in-human
1(9.1%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
8(72.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(6)
Other(3)

Detailed Status

Completed6
unknown3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (9.1%)
Phase 42 (18.2%)
N/A8 (72.7%)

Trials by Status

not_yet_recruiting218%
completed655%
unknown327%

Recent Activity

Clinical Trials (11)

Showing 11 of 11 trials

All 11 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
11